List of Tables
Table 1. Global Complement Inhibitors Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Complement Inhibitors Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Complement Inhibitors Market Competitive Situation by Manufacturers in 2025
Table 4. Global Complement Inhibitors Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Complement Inhibitors Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Complement Inhibitors Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Complement Inhibitors Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Complement Inhibitors Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Complement Inhibitors, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Complement Inhibitors, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Complement Inhibitors, Product Types and Applications
Table 12. Global Key Manufacturers of Complement Inhibitors, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Complement Inhibitors Companies by Tier (Tier 1, Tier 2, Tier 3), based on Complement Inhibitors Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Complement Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Complement Inhibitors Sales by Region (K Units), 2021–2026
Table 18. Global Complement Inhibitors Sales Market Share by Region (2021–2026)
Table 19. Global Complement Inhibitors Sales by Region (K Units), 2027–2032
Table 20. Global Complement Inhibitors Sales Market Share by Region (2027–2032)
Table 21. Global Complement Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 22. Global Complement Inhibitors Revenue Market Share by Region (2021–2026)
Table 23. Global Complement Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 24. Global Complement Inhibitors Revenue Market Share by Region (2027–2032)
Table 25. North America Complement Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Complement Inhibitors Sales by Country (K Units), 2021–2026
Table 27. North America Complement Inhibitors Sales by Country (K Units), 2027–2032
Table 28. North America Complement Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 29. North America Complement Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Complement Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Complement Inhibitors Sales by Country (K Units), 2021–2026
Table 32. Europe Complement Inhibitors Sales by Country (K Units), 2027–2032
Table 33. Europe Complement Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Complement Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Complement Inhibitors Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Complement Inhibitors Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Complement Inhibitors Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Complement Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Complement Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Complement Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Complement Inhibitors Sales by Country (K Units), 2021–2026
Table 42. Latin America Complement Inhibitors Sales by Country (K Units), 2027–2032
Table 43. Latin America Complement Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Complement Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Complement Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Complement Inhibitors Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Complement Inhibitors Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Complement Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Complement Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 50. Global Complement Inhibitors Sales (K Units) by Type (2021–2026)
Table 51. Global Complement Inhibitors Sales (K Units) by Type (2027–2032)
Table 52. Global Complement Inhibitors Sales Market Share by Type (2021–2026)
Table 53. Global Complement Inhibitors Sales Market Share by Type (2027–2032)
Table 54. Global Complement Inhibitors Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Complement Inhibitors Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Complement Inhibitors Revenue Market Share by Type (2021–2026)
Table 57. Global Complement Inhibitors Revenue Market Share by Type (2027–2032)
Table 58. Global Complement Inhibitors Price (US$/Unit) by Type (2021–2026)
Table 59. Global Complement Inhibitors Price (US$/Unit) by Type (2027–2032)
Table 60. Global Complement Inhibitors Sales (K Units) by Application (2021–2026)
Table 61. Global Complement Inhibitors Sales (K Units) by Application (2027–2032)
Table 62. Global Complement Inhibitors Sales Market Share by Application (2021–2026)
Table 63. Global Complement Inhibitors Sales Market Share by Application (2027–2032)
Table 64. Global Complement Inhibitors Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Complement Inhibitors Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Complement Inhibitors Revenue Market Share by Application (2021–2026)
Table 67. Global Complement Inhibitors Revenue Market Share by Application (2027–2032)
Table 68. Global Complement Inhibitors Price (US$/Unit) by Application (2021–2026)
Table 69. Global Complement Inhibitors Price (US$/Unit) by Application (2027–2032)
Table 70. CSL Behring Company Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. CSL Behring Complement Inhibitors Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Takeda Company Information
Table 76. Takeda Description and Business Overview
Table 77. Takeda Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Takeda Complement Inhibitors Product
Table 79. Takeda Recent Developments/Updates
Table 80. Pharming Healthcare Company Information
Table 81. Pharming Healthcare Description and Business Overview
Table 82. Pharming Healthcare Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Pharming Healthcare Complement Inhibitors Product
Table 84. Pharming Healthcare Recent Developments/Updates
Table 85. Sanofi Company Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sanofi Complement Inhibitors Product
Table 89. Sanofi Recent Developments/Updates
Table 90. Apellis Pharmaceuticals Company Information
Table 91. Apellis Pharmaceuticals Description and Business Overview
Table 92. Apellis Pharmaceuticals Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Apellis Pharmaceuticals Complement Inhibitors Product
Table 94. Apellis Pharmaceuticals Recent Developments/Updates
Table 95. UCB Company Information
Table 96. UCB Description and Business Overview
Table 97. UCB Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. UCB Complement Inhibitors Product
Table 99. UCB Recent Developments/Updates
Table 100. Regeneron Pharmaceuticals Company Information
Table 101. Regeneron Pharmaceuticals Description and Business Overview
Table 102. Regeneron Pharmaceuticals Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Regeneron Pharmaceuticals Complement Inhibitors Product
Table 104. Regeneron Pharmaceuticals Recent Developments/Updates
Table 105. Astellas Pharma Company Information
Table 106. Astellas Pharma Description and Business Overview
Table 107. Astellas Pharma Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Astellas Pharma Complement Inhibitors Product
Table 109. Astellas Pharma Recent Developments/Updates
Table 110. Alexion Pharmaceuticals Company Information
Table 111. Alexion Pharmaceuticals Description and Business Overview
Table 112. Alexion Pharmaceuticals Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Alexion Pharmaceuticals Complement Inhibitors Product
Table 114. Alexion Pharmaceuticals Recent Developments/Updates
Table 115. Amgen Company Information
Table 116. Amgen Description and Business Overview
Table 117. Amgen Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Amgen Complement Inhibitors Product
Table 119. Amgen Recent Developments/Updates
Table 120. Roche Company Information
Table 121. Roche Description and Business Overview
Table 122. Roche Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Roche Complement Inhibitors Product
Table 124. Roche Recent Developments/Updates
Table 125. Novartis Company Information
Table 126. Novartis Description and Business Overview
Table 127. Novartis Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Novartis Complement Inhibitors Product
Table 129. Novartis Recent Developments/Updates
Table 130. Samsung Bioepis Company Information
Table 131. Samsung Bioepis Description and Business Overview
Table 132. Samsung Bioepis Complement Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Samsung Bioepis Complement Inhibitors Product
Table 134. Samsung Bioepis Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Complement Inhibitors Distributors List
Table 138. Complement Inhibitors Customers List
Table 139. Complement Inhibitors Market Trends
Table 140. Complement Inhibitors Market Drivers
Table 141. Complement Inhibitors Market Challenges
Table 142. Complement Inhibitors Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Complement Inhibitors
Figure 2. Global Complement Inhibitors Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Complement Inhibitors Market Share by Type: 2025 & 2032
Figure 4. C1 Esterase Inhibitors Product Picture
Figure 5. Complement C3 Inhibitors Product Picture
Figure 6. Complement C5 Inhibitors Product Picture
Figure 7. Complement Factor B Inhibitor Product Picture
Figure 8. Complement Factor D Inhibitor Product Picture
Figure 9. Global Complement Inhibitors Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Complement Inhibitors Market Share by Application: 2025 & 2032
Figure 11. Paroxysmal Nocturnal Hemoglobinuria (PNH)
Figure 12. Atypical Hemolytic Uremic Syndrome (aHUS)
Figure 13. Geographic Atrophy (GA)
Figure 14. Others
Figure 15. Global Complement Inhibitors Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Complement Inhibitors Market Size (US$ Million), 2021–2032
Figure 17. Global Complement Inhibitors Sales (K Units), 2021–2032
Figure 18. Global Complement Inhibitors Average Price (US$/Unit), 2021–2032
Figure 19. Complement Inhibitors Report Years Considered
Figure 20. Complement Inhibitors Sales Share by Manufacturers in 2025
Figure 21. Global Complement Inhibitors Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global Complement Inhibitors Players: Market Share by Revenue in Complement Inhibitors in 2025
Figure 23. Complement Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global Complement Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America Complement Inhibitors Sales Market Share by Country (2021–2032)
Figure 26. North America Complement Inhibitors Revenue Market Share by Country (2021–2032)
Figure 27. United States Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe Complement Inhibitors Sales Market Share by Country (2021–2032)
Figure 30. Europe Complement Inhibitors Revenue Market Share by Country (2021–2032)
Figure 31. Germany Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific Complement Inhibitors Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific Complement Inhibitors Revenue Market Share by Region (2021–2032)
Figure 38. China Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. China Taiwan Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Southeast Asia Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Complement Inhibitors Sales Market Share by Country (2021–2032)
Figure 46. Latin America Complement Inhibitors Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Colombia Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa Complement Inhibitors Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa Complement Inhibitors Revenue Market Share by Country (2021–2032)
Figure 53. Turkey Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. UAE Complement Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of Complement Inhibitors by Type (2021–2032)
Figure 57. Global Revenue Market Share of Complement Inhibitors by Type (2021–2032)
Figure 58. Global Complement Inhibitors Price (US$/Unit) by Type (2021–2032)
Figure 59. Global Sales Market Share of Complement Inhibitors by Application (2021–2032)
Figure 60. Global Revenue Market Share of Complement Inhibitors by Application (2021–2032)
Figure 61. Global Complement Inhibitors Price (US$/Unit) by Application (2021–2032)
Figure 62. Complement Inhibitors Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
